Aurora Cannabis Appears Headed to the New York Stock Exchange

Visit the Aurora Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Aurora Cannabis (TSX: ACB) (OTC: ACBFF) has publicly disclosed that it will be listing on a major exchange in the United States in October, but, until today, the exchange was unknown. The company revealed in a public filing, the Form 40-F, that it has registered to list on the New York Stock Exchange:

Aurora Cannabis hasn’t yet revealed the timing or its trading symbol, though ACB is apparently available. The company will join Canopy Growth (TSX: WEED) (NYSE: CGC), while Cronos Group (TSX: CRON) (NASDAQ: CRON) and Tilray (NASDAQ: TLRY) trade on the NASDAQ. Aleafia (TSXV: ALEF) (OTC: ALEAF) has filed its Form 40-F and intends to trade on the NASDAQ, while it is likely that Aphria (TSX: APH) (OTC: APHQF) and CannTrust (TSX: TRST) (OTC: CNTTF) will list on a major U.S. exchange as well.

Until Cronos Group listed on the NASDAQ earlier this year, no companies growing, processing or selling cannabis had done so with the exception of GW Pharma (NASDAQ: GWPH).

The most reliable, fact-based information on Aurora Cannabis found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Breaking News by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter